What: ‘Caring For The Caregiver’ Program
When: 10 a.m. to 3 p.m. Saturday, June 28
Where: Stabile Research Building at Moffitt Cancer Center, 12902 Magnolia Drive (Tampa, Florida)
Moffitt Cancer Center’s ‘Caring For The Caregiver’ Program is a free education and support program for family cancer caregivers which will be facilitated by Moffitt professionals: Miriam Innocenti (clinical social worker), Jill Blair (nurse practitioner) and Heather Bell (registered dietitian) — and is open to anyone caring for a cancer patient.
Important notes: Light breakfast and lunch are provided. Registration begins at 9:30 a.m. the day of the program. Reservations are required. Please call 1-888-MOFFITT …read more

For the Moffitt Cancer Center’s Department of Nutrition and their Dietitians, March is a month-long celebration of National Nutrition Month.
Together with the other medical disciplines, Dietitians help in providing quality care and comprehensive medical nutrition therapy, including:

Prevention and treatment of malnutrition
Counseling on diet and cancer prevention
Counseling on dietary supplements
Provision of tube-feeding recommendations
Food safety guidance for patients with decreased immunity

The month-long observance of nutrition is geared towards Moffitt patients and employees.
Spot Moffitt dietitians wearing pink on March 10, Registered Dietitian Day. Registered dietitians have degrees in nutrition, dietetics, public health or related fields, and most have a master’s degree. They must …read more

The Moffitt Cancer Center in Tampa, Florida is seeking patients who have primary liver cancer (hepatocellular carcinoma) that has spread to other organs or is too advanced to be treated by surgery and must have had prior chemotherapy treatments.
The said patients are being recruited by Moffitt for the phase II study of the oral medication AZD6244 — an experimental anti-cancer drug that may stop the growth of cancer cells and is designed to block the pathway of a protein called MEK (important for cell survival).
According to Dr. Chris R. Garrett, principal investigator with Moffitt’s Gastrointestinal Oncology program:
“There’s no cure for …read more

We know how green tea has become popular for its anti-cancer ingredients.
Now, Moffitt Cancer Center is looking for volunteers/participants in a green tea study:
Moffitt Cancer Center is looking to recruit and treat 240 men and evaluate safety and effectiveness of Polyphenon E, a drug developed from green tea, in preventing the progression of early signs of prostate cancer.
The goal is to also assess if Polyphenon E reduces urinary tract symptoms that men experience with this condition.
The following male participants are needed:

between the ages of 30 and 80
have had a biopsy-proven high-grade prostatic intraepithelial neoplasia (HGPIN)
have no prior history of other …read more

Pancreatic cancer or cancer of the pancreas doesn’t normally show signs or symptoms until it is too late – making it the fourth leading cause of cancer deaths in the U.S.
November is Pancreatic Cancer Awareness Month.
Moffitt Cancer Center’s Gastrointestinal Oncology Program has an early detection and screening program for pancreatic cancer. This program is the only one of its kind in the Southeast, says Dr. Mokenge P. Malafa, head of the division of Gastrointestinal Oncology. Moffitt doctors and researchers are recruiting for this program and several other innovative clinical trials in pancreatic cancer.
Dr. Jason Klapman, an endoscopic oncologist at Moffitt, …read more

Researchers at the H. Lee Moffitt Cancer Center & Research Institute are testing a new drug – sulindac – to evaluate its potential in reversing the smoking-related damages to the lungs in order to lower the risk of getting lung cancer.
Previous studies have shown that sulindac has been beneficial in preventing the development of pre-cancerous polyps in the colon.
Now, doctors at Moffitt would like to see of the drug will work similarly on the lung’s cells. They’ve opened a new clinical trial are looking for the following patient population:

people between 45 and 79 years old who have smoked at least …read more